|Day's Range||0.44 - 0.50|
|52 Week Range||0.19 - 1.13|
|PE Ratio (TTM)||-3.97|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - June 1, 2017) - The following issues have been halted by IIROC: Company: Oncolytics Biotech Inc. Common share purchase warrants TSX Symbol: ONC.WT ...
By John Vandermosten, CFA OTC:ONCYF On May 8th, Oncolytics Biotech, Inc. (OTC:ONCYF) announced that the FDA had granted Fast Track status to REOLYSIN for the treatment of metastatic breast cancer. Fast ...
The Calgary, Alberta-based company said it had a loss of 2 cents per share. The company's shares closed at 61 cents. A year ago, they were trading at 53 cents. _____ This story was generated by Automated ...